TRACY RICEWICK: Open Payments
NPI 1013365279 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 25 payments from 9 companies in 2025. Trend: 2023 $464 · 2024 $648 · 2025 $462
Food & beverage: $445Education: $16
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $172 |
| Lilly USA, LLC | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Calliditas Therapeutics US Inc. | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Travere Therapeutics, Inc. | 1 | $26 |
| AKEBIA THERAPEUTICS INC | 1 | $25 |
| Ardelyx, Inc. | 1 | $21 |
| OPKO Pharmaceuticals, LLC | 1 | $16 |
Products named: Kerendia, JARDIANCE, TARPEYO, VOYXACT, Vafseo, JYNARQUE, IBSRELA, BRILINTA.
Industry payments across KY — which companies pay providers there.
